The Steritas pGTI: A Critical Tool for Pediatric Lupus Management
A new study led by Joyce Chang, MD MSCE from Boston Children's Hospital and Harvard Medical School, along with researchers from the Children's Hospital of Philadelphia, has underscored the pressing ...
Reshaping the Steroid Paradox
During 2023, the Steritas team had the opportunity to speak with a range of inspiring clinical research leaders who shared their expertise with us and our colleagues. Every conversation underscored ...
Surge in Adoption of the Steritas eCOA Suite Continues
Ever since the introduction of the Steritas Glucocorticoid Toxicity Index (GTI) in 2017, there has been a remarkable surge in the number of clinicians and clinical researchers using Steritas's ...
Ensuring Data Integrity When the Stakes Are High
When the stakes involve patient outcomes and the credibility of clinical trials in the medical, health and pharmaceutical sectors, maintaining data accuracy, integrity and privacy is essential. In ...
Children Experience High Burden from Steroid-toxicity
Early results from a pilot study into the impact of steroid-toxicity on pediatric lupus nephritis patients suggest that children experience a high burden of steroid-toxicity and that variation in ...
Curious about the true cost of steroid-toxicity?
Download our infographic today
